Proposals to enhance the quality of observational cohort studies

Phytomedicine

Volumn 10, Issue 8, 2003, Pages 700-707

  Wegener, T ^a   Schneider, B ^b  

^a Consulting Herbal Medicinal Products ^*  (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anwendungsbeobachtung; Efficacy; Herbal medicinal products; Observational cohort studies; Quality aspects; Safety; Well established medicinal use

Indexed keywords

DRUG EFFICACY; DRUG MONITORING; DRUG RESEARCH; DRUG SAFETY; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; MEDICAL PRACTICE; MEDICAL RESEARCH; PHYTOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 0344629262     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00385     Document Type: Review

References (40)

1. Beneke M, Rasmus W (1992) "Clinical global impressions" (ECDEU): Some critical comments. Pharmacopsychiat 25: 171-176
2. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878-1886
3. Brühlmann P, Stucki G, Michel BA (1994) Evaluation of a German version of the physical dimensions of Health Assessment Questionnaire in patients with rheumatoid arthritis. J Rheumatol 21: 1245-1249
4. BfArM (1994) Bundesinstitut für Arzneimittel und Medizin-produkte. Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln. Empfehlungen zur Planung und Durchführung von Anwendungsbeobachtungen. Bundesanzeiger No. 229, 1998-01-04
5. Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, Fraitag B, Geneve J, Caulin C (1999) Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 44: 527-533
6. Colin-Jones DG (1988) Management of dyspepsia: Report of a working party. Lancet II: 576-579
7. CIPS (1996) Collegium Internationale Psychiatriae Scalarum. Internationale Skalen für Psychiatrie, 4th Ed. Beltz-Test, Göttingen
8. Denes G, Gorbauch T (1990) Arzneimittelforschung nach der Zulassung. Münch med Wschr 132: 373-375
9. EC Proposal for a Directive of the European Parliament and of the Council amending the Directive 2001/83/Ec as regards traditional herbal medicinal products (2002). COM(2002) I final. 2002/0008 (COD)
10. Feinstein AR (1985) Clinical Epidemiology. The Architecture of Clinical Research. W.B. Saunders Company, Philadelphia
11. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum; 38: 727-735
12. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, et al. (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36: 729-740
13. FDA. Food and Drug Administration, Homepage of Guidance Documents issued by the Center for Drug Evaluation and Research (CDER): http://www.fda.gov/cder/ guidance/index.htm
14. Fries JF, Spitz PW, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 32:137-145
15. GPHY (1996). Working party "observational cohort studies" of the German Society of Phytotherapy. Empfehlungen der Gesellschaft für Phytotherapie (GPHY) zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen. Klin Pharmakol akt 7: 76-83
16. Hotz J, Enck P, Goebell H, Heymann-Monnikes I, Holtmann G, Layer P (1999) Konsensusbericht: Reizdarmsyndrom -Definition, Diagnosesicherung, Pathophysiologie und Therapiemöglichkeiten. Z Gastroenterol 37: 685-700
17. Hönig R, Eberhardt R, Kori-Lindner C, Langen M (eds) (1998) Anwendungsbeobachtung. Qualitätsstandards, praktische Durchführung, Beitrag zur Arzneimittelsicherheit und Nachzulassung. E. Habrich, Berlin
18. Kraft K, Loew D, Schneider B, Kemper FH (1997) Planung, Durchführung und Auswertung von Anwendungsbeobachtungen. Empfehlungen der Gesellschaft für Phytotherapie (GPHY). Pharm Ind 59: 755-759
19. Leidy NK, Farup C, Rentz AM, Ganoczy D, Koch KL (2000) Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI). Digestive Dis Scien 45: 1172-1179
20. Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for OA of the hip and knee. Scand J Rheumatol 65 (Suppl): 85-89
21. Linden M, Baier D, Beitinger H, Kohnen R, Osterheider M, Philipp M, Reimitz PE, Schaaf B, Weber HJ (1994) Leitlinien zur Durchführung von Anwendungsbeobachtungen (AWB) in der Psychopharmakotherapie. Nervenarzt 65: 638-644
22. Manniche C, Asmussen K, Lauritsen B, Vinterberg H, Kreiner S, Jordan A (1994) Low Back Pain Rating scale: validation of a tool for assessment of low back pain. Pain 57: 317-326
23. Mearin F, Balboa A, Zarate N, Cucala M, Malagelada JR (1999) Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 94: 116-125
24. MCA (1994) Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association, Association of British Pharmaceutical Industry. Guidelines for company-sponsored safety assessment of marketed medicines (SAMM). Pharmacoepidemiology & Drug Safety 3: 1-6
25. Müller-Lissner S, Koelz HR (1992) Dyspepsie: Definition, Ursachen und Vorgehen. Dt Ärztebl 89: B1420-B1425
26. Müller-Lissner SA, Klauser AG (1999) Funktionelle abdominelle Beschwerden. Funktionelle Dyspepsie und irritables Kolon. Internist 40: 543-554
27. Paulus HE, Egger MJ, Ward JR, Williams HJ (1990) Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs based on findings in patients treated with placebo. Arthritis Rheum 33: 477-484
28. Rosenbaum PR, Rubin DB (1983) The central role of propensity score in observational studies for causal effects. Biometrika 70: 41-55
29. Sandha GS, Hunt RH, Veldhuyzen van Zanten SJ (1999) A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and - negative non-ulcer dyspepsia. Scand J Gastroenterol 34: 244-249
30. Sangha O, Stucki G (1997) Patienten-zentrierte Evaluation der Krankheitsauswirkungen bei muskuloskelettalen Erkrankungen: Übersicht über die wichtigsten Outcome-Instrumente. Z Rheumatol 56: 322-333
31. Selbmann HK (1996) Checkliste für Publikationen von Anwendungsbeobachtungen. Fortschr Med 114: 123-124
32. Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W, Theiler R (1996) Evaluation einer deutschen Version des WOMAC (Western-Ontario-and- McMaster Universities)-Arthrose-Index. Z Rheumatol 55: 40-49
33. Stucki G (1997) Outcome-Meßinstrumente zur Beurteilung der klinischen Ergebnisqualität. Akt Rheumatol 22 (Suppl 1): S3-S5
34. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M (1999) Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 13: 225-235
35. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN (1999) Functional gastroduodenal disorders. Gut 45 (Suppl 1): II37-II42
36. Talley NJ, Verlinden M, Jones M (1999) Validity of a new quality of life scale for functional dyspepsia: A United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 94: 2390-2397
37. Victor N, Windeler J, Hasford J, Kopcke W, Linden M, Michaelis J, Röhmel J, Schäfer H (1997) Empfehlungen der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie GMDS. Empfehlungen zur Durchführung von Anwendungsbeobachtungen. Inf Biom Epidem Med Biol 28: 247-252
38. Waller PC, Wood SM, Longman MJS, Breckenridge AM, Rawlins MD (1992) Review of company postmarketing surveillance studies. BMJ 304: 1470-1472
39. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P (1998) Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 583: 41-49
40. Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM (2001) Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol 96: 285-297